Illustration for the Biotech & Life Support sector, not a picture of the company.

Biotech & Life SupportThe Human Hardware

Vertex Pharma

VRTXHOLDPublic · USA

Biotech developing transformative therapies for serious diseases including genetic disorders Visit website

$540.00

▲ +1.9% as of Oct 29

CONVICTION SCORE

46

On Track

Execution Velocity

Score computed, inputs as of Oct 2026 · signal and velocity are editorial

WHY THIS SCORE

Methodology

Execution4040%

Wins in the Feed: not measured: no sourced item about this company in the Feed in 90 days
Orbital launches: not applicable: not an orbital launch provider that has flown
Revenue growth: 40, +10% a year, trailing twelve months (lower than the quarter)

Milestones4525%

Ladder 0: not a named contributor to any rung on the Dew Point ladder
Own timelines 90: execution velocity On Track, editorial and ledgered

Signals5020%

Feed: nothing sourced in 90 days (neutral)
Form 4: 0 open-market purchases, 0 sales outside a 10b5-1 plan, in 90 days (+0)

Coverage6015%

Breadth 50: 1 sector
Scarcity 75: Biotech & Life Support has 4 covered names

0.40 × 40 + 0.25 × 45 + 0.20 × 50 + 0.15 × 60 = 46.3 → 46

No editorial adjustment. A reviewer may move a computed score by up to 10 points with a reason, recorded on the scorecard.

Inputs frozen Oct 23, 2026 from the site's own feeds: the Feed and Form 4 over 90 days, launches over 365 days, revenue over the trailing year. Next review by Jan 21, 2027. The share price and analyst ratings are not inputs.